Advancing non-invasive healthcare through validated cfDNA solutions

Helping genomic healthcare professionals and researchers improve patient care.

See our range of liquid biopsy products below


Ensuring successful cell-free DNA analysis is our focus

Every sample is precious and to get the most out of your sample when evaluating cell-free DNA it is really critical to have processed your samples correctly from blood collection through to extracted cfDNA. Learn more about our Cell3™ Preserver blood tube and Cell3™ Xtract kit below.


Efficient workflow enables confident calling of all ctDNA mutations

Nonacus are working with some of the brightest scientists and clinicians by providing a validated complete workflow for liquid biopsy analysis. With the ultimate goal of enabling better cancer care through earlier diagnosis, treatment stratification and monitoring.

Prenatal healthcare

Non-invasive prenatal testing requires sensitive, reproducible and easy to use products

Nonacus continues to develop innovative products to meet these exacting standards including tests for fetal rhesus-D genotyping, fetal fraction quantitation and single gene disorder testing.

Who we are

Designed by scientists, for scientists

We are formed of a committed group of biotechnology professionals with a combined 35 years experience in genomic healthcare. We understand the pressure on laboratories to deliver progress and our products are designed to get you there. Between us, we’ve got global experience of genomic healthcare from the NHS in the UK through to an international genome project.

Scientist working in a lab
Test Tubes filled with red solutions sat next to red stethoscope

What we stand for

True innovation that benefits patients

We translate research into routine diagnostic tools that directly benefit patients and scientists. Our non-invasive cell-free DNA solutions improve diagnostic accuracy as well as the patient’s experience. Our research & development team are constantly developing, validating and testing new cfDNA products.

Built for


We supply Universities with our cfDNA products to help them improve their understanding and research in non-invasive healthcare.


Leading hospitals have adopted our products to help improve patient care through the innovative use of cfDNA technology allowing for non-invasive diagnostics.

Research Facilities

We partner with many leading laboratories to constantly innovate and push our cfDNA products further.

Pipette filling up test tubs with clear liquid

Read our latest insights

Introducing our new logo and brand identity: reflecting Nonacus’ clinical vision for advanced liquid biopsy testing

May 26, 2023

The new Nonacus logo and rebranding effort signifies our commitment to advancing clinical solutions that revolutionize cancer diagnostics and treatment.

Read More

Bladder Cancer Awareness Month: The potential of a non-invasive approach

May 25, 2023

As we continue to implement GALEAS® Bladder, we want to use Bladder Cancer Awareness Month to raise awareness of the disease and emphasize the importance of discussions around bladder cancer and knowledge of early symptoms.

Read More

Liquid biopsy company Nonacus unveils new Birmingham headquarters with distinguished presence of Angela Douglas MBE

May 17, 2023

Liquid biopsy company Nonacus and genomic testing laboratory Informed Genomics officially opened their new Birmingham Headquarters yesterday with a ribbon-cutting ceremony led by Angela Douglas MBE, Deputy Chief Scientific Officer for NHS England.

Read More

Are you ready to innovate your cfDNA capability?

Contact us for a quote.